Sales Up, Profit Flat For Abbott

BMI view: US-based Abbott Laboratories will outperform its peers over the medium term. The diversified biopharmaceutical company has a growing presence in non-traditional markets, thereby offsetting limited growth in its domestic market. Abbott also develops therapeutics in combination with diagnostics, which is one of our core views for the industry.

To read the full article, please choose one of the following options: